ALKERMES PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.1 USD | -0.78% |
|
-3.41% | -13.12% |
| 06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
| 06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.08B | ||||||
| 39.36B | ||||||
| 38.52B | ||||||
| 30.74B | - | |||||
| 25.92B | ||||||
| 26.03B |
- Stock Market
- Equities
- ALKS Stock
- Charts Alkermes plc
- Sector Chart
